Cargando…

Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study

This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register...

Descripción completa

Detalles Bibliográficos
Autores principales: Berg, Selina Kikkenborg, Wallach-Kildemoes, Helle, Rasmussen, Line Ryberg, Nygaard, Ulrikka, Bundgaard, Henning, Petersen, Maria Nivi Schmidt, Hammer, Cecilie Bech, Ersbøll, Annette Kjær, Thygesen, Lau Caspar, Nielsen, Susanne Dam, Christensen, Anne Vinggaard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692356/
https://www.ncbi.nlm.nih.gov/pubmed/36366371
http://dx.doi.org/10.3390/vaccines10111863
_version_ 1784837244640559104
author Berg, Selina Kikkenborg
Wallach-Kildemoes, Helle
Rasmussen, Line Ryberg
Nygaard, Ulrikka
Bundgaard, Henning
Petersen, Maria Nivi Schmidt
Hammer, Cecilie Bech
Ersbøll, Annette Kjær
Thygesen, Lau Caspar
Nielsen, Susanne Dam
Christensen, Anne Vinggaard
author_facet Berg, Selina Kikkenborg
Wallach-Kildemoes, Helle
Rasmussen, Line Ryberg
Nygaard, Ulrikka
Bundgaard, Henning
Petersen, Maria Nivi Schmidt
Hammer, Cecilie Bech
Ersbøll, Annette Kjær
Thygesen, Lau Caspar
Nielsen, Susanne Dam
Christensen, Anne Vinggaard
author_sort Berg, Selina Kikkenborg
collection PubMed
description This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size.
format Online
Article
Text
id pubmed-9692356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96923562022-11-26 Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study Berg, Selina Kikkenborg Wallach-Kildemoes, Helle Rasmussen, Line Ryberg Nygaard, Ulrikka Bundgaard, Henning Petersen, Maria Nivi Schmidt Hammer, Cecilie Bech Ersbøll, Annette Kjær Thygesen, Lau Caspar Nielsen, Susanne Dam Christensen, Anne Vinggaard Vaccines (Basel) Article This study investigated self-reported short- and long-term symptoms among adolescents receiving the BNT162b2 (Pfizer/BioNTech) vaccine against SARS-CoV-2 and those who did not. A retrospective cohort study based on Danish national survey (collected between 20 July and 15 September 2021) and register data was conducted. Differences in short-term (<14 days) and long-term (>two months) symptoms were explored using logistic regression adjusted for confounders. A total of 747 vaccinated (first dose n = 326; second dose n = 421) and 6300 unvaccinated adolescents were included in analyses of short-term symptoms and 32 vaccinated and 704 unvaccinated adolescents in long-term symptom analyses. In the first 14 days after the first and second vaccine dose the most reported symptoms included headache and muscle or joint symptoms. In both vaccinated and unvaccinated adolescents, the 15–19-year-olds reported significantly higher proportions of all symptoms compared to the 12–14-year-olds. After the second vaccine dose vaccinated 12–14-year-olds reported significantly more headache in adjusted analyses (OR 2.20 (95% CI 1.24; 3.90)). Among the 15–19-year-olds, significantly more vaccinated adolescents reported gastrointestinal symptoms (1.38 (1.06; 1.81)), headache (1.66 (1.24; 2.22)), and tiredness (1.44 (1.08; 1.93)). No differences were found in long-term symptoms. Vaccinated adolescents reported significantly more short-term symptoms including headache, tiredness, and gastrointestinal symptoms after the second vaccine dose than unvaccinated adolescents. Long-term symptom results should be interpreted with caution due to limited sample size. MDPI 2022-11-04 /pmc/articles/PMC9692356/ /pubmed/36366371 http://dx.doi.org/10.3390/vaccines10111863 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Berg, Selina Kikkenborg
Wallach-Kildemoes, Helle
Rasmussen, Line Ryberg
Nygaard, Ulrikka
Bundgaard, Henning
Petersen, Maria Nivi Schmidt
Hammer, Cecilie Bech
Ersbøll, Annette Kjær
Thygesen, Lau Caspar
Nielsen, Susanne Dam
Christensen, Anne Vinggaard
Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_full Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_fullStr Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_full_unstemmed Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_short Short- and Long-Term Self-Reported Symptoms in Adolescents Aged 12–19 Years after Vaccination against SARS-CoV-2 Compared to Adolescents Not Vaccinated—A Danish Retrospective Cohort Study
title_sort short- and long-term self-reported symptoms in adolescents aged 12–19 years after vaccination against sars-cov-2 compared to adolescents not vaccinated—a danish retrospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692356/
https://www.ncbi.nlm.nih.gov/pubmed/36366371
http://dx.doi.org/10.3390/vaccines10111863
work_keys_str_mv AT bergselinakikkenborg shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT wallachkildemoeshelle shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT rasmussenlineryberg shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT nygaardulrikka shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT bundgaardhenning shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT petersenmarianivischmidt shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT hammerceciliebech shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT ersbøllannettekjær shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT thygesenlaucaspar shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT nielsensusannedam shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy
AT christensenannevinggaard shortandlongtermselfreportedsymptomsinadolescentsaged1219yearsaftervaccinationagainstsarscov2comparedtoadolescentsnotvaccinatedadanishretrospectivecohortstudy